Home › Metastatic Cancer › NCT06015932
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
A Non-Randomized Translational Trial of Cognitive Behavioral Cancer Stress Management (CBCSM) and Its Effects on Cancer Distress
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Eligible for the cognitive behavioral cancer stress management (CBCSM) clinical service * Cancer diagnosis with predicted survival \> 1 year * Cancer treatment within past 1 year or treatment planning in progress * Age \>= 18-years * Moderate distress screen, indicated by Impact of Event Scale-Revised (IES-R) score \>= 14 or clinical judgment * Written informed research consent Exclusion Criteria: * Inability to actively participate in and learn from group therapy (e.g., psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgment in clinical consultation (Individual therapy or alternative group therapy will be offered)
About the study
This clinical trial tests how well cognitive behavioral cancer stress management (CBCSM) group sessions work to decrease psychological distress in cancer patients. CBCSM teaches patients how to recognize and reduce the impacts of cancer associated stress on the biological, psychological, and social life domains.
What is being tested
- Cognitive Behavior Therapy (behavioral)
- Questionnaire Administration (other)
Sponsor: Mayo Clinic · Participants: 400 · Started: Dec 20, 2017
Contact the study team
- Clinical Trials Referral Office · Phone: 855-776-0015
- Deanna Hofschulte · Phone: 507-255-2972
Official record on ClinicalTrials.gov — NCT06015932
Locations in the U.S.
| Minnesota | Mayo Clinic in Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.